CCL14 and acute kidney injury: CCL-14 was found to predict persisting AKI after cardiac surgery with an AUC of 0.930 (95% CI, 0.881–0.979) and renal replacement therapy within 7 days with an AUC of 0.915 (95% CI, 0.858–0.972).